Milly E. de Jonge
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Pharmaceutical studies and practices
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Pharmaceutical studies and practices 6
- Co-authors
- Jos H. Beijnen (18 shared papers)Sjoerd Rodenhuis (16 shared papers)Alwin D. R. Huitema (16 shared papers)Jan H.M. Schellens (4 shared papers)Ron A. A. Mathôt (4 shared papers)Hilde Rosing (2 shared papers)M. Holtkamp (1 shared paper)Otilia Dalesio (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Clinical Cancer Research (3 papers)Therapeutic Drug Monitoring (3 papers)Clinical Pharmacokinetics (2 papers)Journal of Mass Spectrometry (1 paper)
- Partner nations
- Netherlands
In The Last Decade
Milly E. de Jonge
18 papers receiving 960 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 305
- Pediatrics, Perinatology and Child Health 148
- Hematology 79
- Statistics and Probability 72
- Analytical Chemistry 55
Countries citing papers authored by Milly E. de Jonge
This map shows the geographic impact of Milly E. de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milly E. de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milly E. de Jonge more than expected).
Fields of papers citing papers by Milly E. de Jonge
This network shows the impact of papers produced by Milly E. de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milly E. de Jonge. The network helps show where Milly E. de Jonge may publish in the future.
Co-authors
The 17 scholars most cited alongside Milly E. de Jonge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 364 | |
| 2 | 2005 | 95 | |
| 3 | 2005 | 71 | |
| 4 | 2006 | 65 | |
| 5 | 2005 | 56 | |
| 6 | 2004 | 46 | |
| 7 | 2004 | 45 | |
| 8 | 2006 | 44 | |
| 9 | 2002 | 40 | |
| 10 | 2002 | 39 | |
| 11 | 2005 | 31 | |
| 12 | 2005 | 25 | |
| 13 | 2005 | 24 | |
| 14 | 2004 | 22 | |
| 15 | 2005 | 20 | |
| 16 | 2005 | 12 | |
| 17 | 2003 | 6 | |
| 18 | 2005 | 5 |
About Milly E. de Jonge
Milly E. de Jonge is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Pharmacology, Oncology and Statistics and Probability, having authored 18 papers that have together received 1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Pharmaceutical studies and practices (6 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Cancer Treatment and Pharmacology (2 papers), Statistical Methods in Clinical Trials (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Pharmacology (305 citations), Pediatrics, Perinatology and Child Health (148 citations), Hematology (79 citations), Statistics and Probability (72 citations) and Analytical Chemistry (55 citations). Milly E. de Jonge has collaborated with scholars based in Netherlands. Frequent co-authors include Jos H. Beijnen, Sjoerd Rodenhuis, Alwin D. R. Huitema, Jan H.M. Schellens, Ron A. A. Mathôt, Hilde Rosing, M. Holtkamp, Otilia Dalesio, Corine Ekhart and Michel J. X. Hillebrand. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Therapeutic Drug Monitoring, Clinical Pharmacokinetics and Journal of Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.